VI-0521
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for VI-0521, covering 2009-12-01 to 2024-06-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects [Phase 4]